Drug Utilization Review Board Meeting Materials
Meeting information is retained on this page for 7 years then sent to the Missouri State Archives.
Register for Public Comment
Any interested party shall be granted the opportunity for clinically relevant public comment for up to three (3) minutes per medication under review by the DUR. The responsibility of scheduling the presentation shall rest with the interested party, and registration must be completed prior to the scheduled meeting. Interested parties representing a manufacturer shall be granted three (3) minutes in the aggregate per medication under review by the DUR.
2020
October 21, 2020
DUR Criteria
Clinical Edit Proposals – Existing Criteria
Media
DUR Criteria
Conduent Reports
DUR Criteria
Preferred Drug List Proposed Edits
Media
July 15, 2020
DUR Criteria
Clinical and Fiscal Edits
Media
DUR Criteria
Preferred Drug List Proposed Edits
Media
April 15, 2020
DUR Criteria
Clinical Edits - No New Criteria
Media
DUR Criteria
Preferred Drug List Proposed Edits
Media